Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Zymeworks (ZYME) Misses Q4 EPS, Revenue Beats
March 7, 2023 4:14 PM ESTZymeworks (NASDAQ: ZYME) reported Q4 EPS of $4.71, $0.13 worse than the analyst estimate of $4.84. Revenue for the quarter came in at $402.49 million versus the consensus estimate of $371.3 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
... More